Bill Miller’s ANI Pharmaceuticals ANIP Stock Holding History

Bill Miller’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,000	Closed	-$334K	–	112
2018 Q2	$334K	Hold	5,000	–	–	0.01%	101
2018 Q1	$291K	Hold	5,000	–	–	0.01%	100
2017 Q4	$322K	Buy	+5,000	New	+$311K	0.01%	100

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bill Miller's ANIP Position: Q3 2018 in Review

Bill Miller sold out of ANI Pharmaceuticals (ANIP) in Q3 2018, closing a stake of 5,000 shares — an estimated $334K sold.

Bill Miller first reported a position in ANIP in Q4 2017 and held it in 3 quarters. The position peaked at $334K in Q2 2018. 173 funds tracked by Wall St. Rank hold ANIP as of Q3 2018.

Bill Miller reported no remaining ANI Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Bill Miller sold 5,000 ANI Pharmaceuticals shares in Q3 2018, an estimated $334K.
Bill Miller first reported a position in ANI Pharmaceuticals in Q4 2017 and held it in 3 quarters.
Bill Miller's ANI Pharmaceuticals position peaked at $334K in Q2 2018.
173 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2018.

Based on Miller Value Partners's 13F filing for Q3 2018, filed 14 Nov 2018.